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Background
Neurotrophins (nerve growth factor, NGF; brain-derived
neurotrophic factor, BDNF; neurotrophin-3, NT-3) are
involved in various CNS functions from differentiation
and neuron survival to synaptogenesis and synaptic plas-
ticity. They are synthesized in neurons and also in nonen-
uronal cells (astrocytes), which therefore represent an
important local source of trophic support in normal and
diseased bran. Their synthesis in astrocytes is susceptible
to up-regulation by cytokines, hormones, drugs and syn-
aptically released neurotransmitters. They all show signif-
icant but diverse regulatory effects on neurotrophin levels
in astrocytes with differences in dose-dependency and
short-term kinetics. Cytokines are the most effective stim-
ulators of NGF synthesis and/or secretion, whereas the
monoaminergic neurotransmitters noradrenaline, adren-
alin, 5-HT, dopamine and histamine differentially affect
synthesis of all three neurotrophins. Their stimulatory
effect is a specific receptor-mediated process involving
either cytokine (IL-1), adrenergic (α1, β1/β2), dopaminer-
gic (D1) or histamine (H1, H2, H3) receptors and corre-
sponding intracellular mechanisms.
Summary
In conclusion, the studies on the mechanisms of astrocytic
neurotrophin regulation suggest the importance of posi-
tive cooperation between the excitatory monoaminergic
neuronal activity and astrocytic neurotrophic support
(neuron-astrocyte crosstalk) in the developing, mature
and diseased brain.
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